The National Pharmaceutical Pricing Authority (NPPA) on Friday asked the makers of key drugs like FDC Lopinavir and Ritonavir, hydroxychloroquine, azithromycin and paracetamol to submit report abouttheir stock availability with a view to deal with the situation arising out of COVID-19 pandemic.
Invoking powers given under the para 29 - maintenance of records and production thereof for inspection - of the Drug Prices Control Order 2013, the regulatorasked the drug manufacturers of medicines namely FDC Lopinavir and Ritonavir (200mg+50 mg), Hydroxychloroquine 200 mgand 400 mg, Azithromycin 250 mg and 500 mg and Paracetamol 500 mg to submit the information by 6 pm in a prescribed proforma.
It asked the companies to provide details such as their names, installed capacity tablets per day, total stock in-hand in number of tablets, commitment for exports in number of tablets, domestic commitment in number of tablets, currentstock of API in KG,
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app